American Board of Internal Medicine home page

Initial Certification indicates that physicians have met rigorous standards through intensive study, accredited training and evaluation and that they have the clinical judgment, skills and attitudes essential for the delivery of excellent patient care.

MOC is a professionally determined standard that attests that an internist is staying current in knowledge and practice throughout his/her career.

For more than 75 years, Certification by ABIM has stood for the highest standard in internal medicine and its 20 subspecialties.

Pulmonary Disease Board

Serpil C. Erzurum, MD, Chair

Dr. Erzurum is the Alfred Lerner Chair of the Department of Pathobiology in the Lerner Research Institute, and the Program Director of the Cleveland Clinic Clinical Research Unit of the Case Clinical Translational Science Center. In these roles, she led development of translational multidisciplinary research programs to investigate human diseases. Since 1993, she has practiced as an ABIM Board Certified pulmonologist at the Cleveland Clinic. She also holds certifications in internal medicine and critical care medicine.

Prior to the Cleveland Clinic, Dr. Erzurum practiced at the University of Pittsburgh Medical Center, in the Indian Health Service in South Dakota, and as a senior staff fellow in the pulmonary branch of the National Heart Lung and Blood Institute (NHLBI). Over the past 25 years, her NIH-funded studies of asthma and pulmonary vascular diseases have uncovered mechanisms and led to new therapeutic concepts.

She is a member of the Board of External Experts and Board of Scientific Counselors for NHLBI, and a Councilor of the Association of American Physicians. Dr. Erzurum chairs the research committee of the Scientific Leadership Council of the Pulmonary Hypertension Association, and has been a senior fellow of the American Asthma Foundation. She is deputy editor of the American Journal of Respiratory and Critical Care Medicine since 2009. She serves on the American Board of Internal Medicine (ABIM) Council, is Chair of the ABIM Pulmonary Disease Board and is a former member of the ABIM Pulmonary Disease Board Exam Committee.

Dr. Erzurum received her medical degree in 1983 from Northeastern Ohio Universities College of Medicine. Following medicine residency at Baylor College of Medicine, she trained in pulmonary and critical care at the University of Colorado and National Jewish Center.

As of January 2017, Dr. Erzurum reported no external relationships.

Kevin M. Chan, MD

Dr. Chan, who is board certified in Internal Medicine, Pulmonary Disease and Critical Care Medicine, is Fellowship Program Director for the Division of Pulmonary and Critical Care Medicine and Medical Director of Lung Transplantation at the University of Michigan. His academic career has centered on house officer education, end-stage lung disease and the infectious complications of lung transplantation.

Currently, Dr. Chan serves as the American College of Chest Physician's (ACCP) representative to the American Board of Internal Medicine (ABIM) Liaison Committee on Certification and Recertification. He is the Maintenance of Certification (MOC) Workforce Chair for the ACCP and the Thoracic Committee Vice-Chair for the United Network for Organ Sharing (UNOS). Dr. Chan is a member of the ABIM Pulmonary Disease Board. He has served as Scientific Program Chair (2011) for the ACCP and as Chair of the National Lung Review Board and Region 10 representative for UNOS.

Dr. Chan earned his medical degree at Wayne State University in Detroit, Michigan. He did his residency in internal medicine at Rush-Presbyterian-St. Luke's Medical Center in Chicago and completed his pulmonary and critical care medicine fellowship training at the University of California Los Angeles Center for the Health Sciences.

As of January 2017, Dr. Chan reported the following external relationships:

Clinical research, with funding for clinical trial expenses and clinical research staff, paid directly to the University of Michigan Health Systems from the following company:

  • Gilead, to support the evaluation of an oral medication to treat respiratory syncytial virus infection in lung transplant recipients.

Dr. Chan serves in significant roles with the following healthcare-related organizations, receiving reimbursement or compensation as listed:

  • American College of Chest Physicians, serving as the MOC Workforce Chair and Vice Chair of the Membership Committee, receiving reimbursement for travel expenses.
  • Minority Organ and Tissue Transplant Education Program (MOTTEP) Michigan, serving on the Board of Directors, without compensation.
  • United Network for Organ Sharing, serving as Vice Chair, Thoracic Committee, receiving reimbursement for travel expenses.

Funding for clinical trial expenses and clinical research staff, paid directly to the University of Michigan Health Systems from the following company:

  • Washington University, to support the evaluation of extracorporeal photopheresis for the treatment of obliterative bronchiolitis in lung transplant recipients.

John H. Hansen-Faschen, MD

Dr. Hansen-Flaschen is the Paul F. Harron Family Professor of Medicine at the University of Pennsylvania. He co-directs the Paul Harron Lung Center, which he founded at Penn, and he serves as the Founding Editor-in-Chief of the Annals of the American Thoracic

Dr. Hansen-Flaschen is board certified in both Internal Medicine and Pulmonary Disease. In addition to his administrative and editorial responsibilities, he practices consultative pulmonary medicine special focus on diagnostic dilemmas and second opinions. He also leads the multidisciplinary Nontuberculous Mycobacteria Lung Infection Clinic at Penn.

His scholarly interests focus on shared medical decision making near the end of life and on humanizing the experience of patients and family members in intensive care units. Dr. Hansen-Flaschen has published more than 90 articles and textbook chapters and has edited three books. He lectures and teaches nationally and internationally on management of advanced lung diseases near the end of life and related topics. He is a member of the American Board of Internal Medicine (ABIM) Pulmonary Disease Board and was previously a member of the ABIM Pulmonary Disease Board Exam Committee.

Previously, Dr. Hansen-Flaschen served for 25 years as the Chief of the Pulmonary, Allergy and Critical Care Division of the Department of Medicine at Penn. He built the full-time clinical and research faculty of the division to 60 members. First as the Pulmonary Fellowship Training Program Director and then as Division Chief, he also oversaw the training of more than 180 pulmonary and critical care fellows between 1982 and 2014.

Dr. Hansen-Flaschen completed his bachelor's degree in chemistry with honors at Brown University and received his medical degree from New York University. He served as a resident and chief resident in medicine and then as a fellow in pulmonary and critical care medicine at the Hospital of the University of Pennsylvania.

As of January 2017, Dr. Hansen-Faschen reported the following external relationships:

Work as an author or editor for following companies, with compensation as listed:

  • UpToDate, receiving compensation for authorship.
  • American Thoracic Society, receiving compensation as Editor-in-Chief of the Annals of the American Thoracic Society, paid to the University of Pennsylvania.

Dean Hess, PhD

Dr. Hess is Assistant Director of Respiratory Care at Massachusetts General Hospital and Associate Professor of Anesthesia at Harvard Medical School in Boston, Massachusetts. He has more than 40 years of experience in respiratory care, including clinical, research, teaching and administrative responsibilities.

Since January 2008, Dr. Hess has been Editor in Chief of Respiratory Care, the official science journal of the American Association for Respiratory Care. He is on the Editorial Boards of the Journal of Aerosol Medicine and Pulmonary Drug Delivery, and Simulation in Healthcare. His research interests include aerosol delivery techniques, adult mechanical ventilation and critical care monitoring. He is a Fellow of the American Association for Respiratory Care, the American College of Chest Physicians and the American College of Critical Care Medicine.

Dr. Hess has published more than 200 papers and several books. He has had committee appointments with the American Association for Respiratory Care, the American College of Chest Physicians, the American Thoracic Society, the Society for Critical Care Medicine, and has served two years as President of the National Board for Respiratory Care. Dr. Hess is also a member of the American Board of Internal Medicine Pulmonary Disease Board. He has lectured extensively throughout the United States and around the world. He has received numerous awards including the Jimmy A. Young Medal (2006); Robert H. Miller Award (2007); Shubin-Weil Master Clinician/Teacher (2009); Chadwick Medal (2011); and the Society of Critical Care Medicine Presidential Citation (2012).

As of January 2017, Dr. Hess reported the following external relationships:

Consulting on design of new drugs or devices, clinical trials, the use of specific agents or other research-related activities for the following company, with compensation for travel expenses and honoraria:

  • Philips Respironics, assisting with the development of a new mechanical ventilator, receiving reimbursement for travel expenses and honoraria.

Work as an author or editor for following companies, with compensation as listed:

  • Jones & Bartlett Learning, receiving royalties for authorship.
  • Daedalus, receiving compensation as Editor in Chief, Respiratory Care.
  • UpToDate, receiving compensation for authorship.
  • McGraw-Hill, receiving compensation for authorship.

Dr. Hess serves in significant roles with the following healthcare-related organizations, receiving reimbursement or compensation as listed:

  • American Association for Respiratory Care, serving on the Program Committee and as a Speaker at Congress, receiving reimbursement for travel expenses and honoraria.
  • American Thoracic Society, serving on Guidelines Writing Committee and Membership Committee, receiving reimbursement for travel expenses.
  • Society of Critical Care Medicine, serving as a Speaker at Congress and on a Nomination Committee, receiving reimbursement for travel expenses.

Funding for clinical trial expenses and clinical research staff, paid directly to Massachusetts General Hospital, from the following company:

  • NIH, for a study of the influence of sGC genotype on response to inhaled nitric oxide in healthy volunteers; a study of the influence of sGC genotype on response to inhaled nitric oxide in healthy volunteers; and for a study of cytoprotection by carbon monoxide in sepsis and acute respiratory distress syndrome.

Dr. Hess also reported serving as a consultant for Ventac.

Tommye Lambert, MDIV

Ms. Lambert is the Founder and President of Live and Proclaim Ministries. Prior to this, for 28 years, Ms. Lambert was the primary caregiver to her daughter, who suffered with cystic fibrosis. During that time, she interacted with pulmonary care clinicians at five centers, including critical care and transplant teams. She was a leader in the caregiver community providing training and facilitating discussions focused on assisting in improved patient care through patient-doctor communication and collaboration. Today, she serves on the American Board of Internal Medicine as an At-Large Member of the Pulmonary Disease Board.

Since 2002, Ms. Lambert has focused her work on the compassionate care of the community as a member of the clergy. She has served as minister to adults at Hunter Street Baptist Church, addressing the educational and counseling needs of single adults, women and married couples in a congregation of 7,000. During her tenure, the church has published a variety of biblically based curricula, small group lessons and inspirational devotional journals written and edited by Ms. Lambert.

Prior to clergy service, Ms. Lambert worked in clinical laboratory medicine for 17 years. The last 10 years of her health care career, she served at Roche Biomedical Laboratories, Clinical Laboratory Division as the General Regional Manager, Southeastern Region, Regional Project Manager and the Regional Training Director.

Ms. Lambert earned a master's degree in divinity at Beeson Divinity School, Samford University; an executive MBA from the University of Alabama; and a bachelor's degree in medical technology from the University of Southern Mississippi. She is pursuing a Doctor of Ministry at Beeson Divinity School. Her dissertation research is related to the application of theology in daily living (Christian ethics), and her upcoming praxis will be based upon the ethical decisions pursuant to the challenges of daily life and end-of-life decisions of the chronically ill.

As of January 2017, Ms. Lambert reported no external relationships.

Michael E. Nelson, MD

Dr. Nelson is a practicing physician in Shawnee Mission, Kansas. He is a member of the staff of Shawnee Mission Medical Center, where he has previously served as the Chairman of the Department of Internal Medicine. He is currently the Medical Director of the Sleep Laboratory. His certifications from the American Board of Internal Medicine (ABIM) include Internal Medicine, Pulmonary Disease, Critical Care Medicine and Sleep Medicine. He also holds a certification in Sleep Medicine from the American Board of Sleep Medicine.

Currently, Dr. Nelson serves as a member of the ABIM Pulmonary Disease Board. He is also a member of the Education Committee and the Clinical Practice Committee of the American Thoracic Society (ATS). He has been an active participant in the educational programs of the American College of Physicians and the American College of Chest Physicians (ACCP). Dr. Nelson serves as the Alternate Advisor to the American Medical Association's Current Procedural Terminology Committee for the ACCP and the ATS.

Dr. Nelson earned his medical degree at the University of Kansas School of Medicine. He completed his residency and chief residency in internal medicine, as well as a fellowship in pulmonary and critical care medicine, at the Department of Medicine at the University of Kansas.

As of January 2017, Dr. Nelson reported the following external relationships:

Dr. Nelson serves in significant roles with the following healthcare-related organization, receiving reimbursement or compensation as listed:

  • American College of Chest Physicians, Board of Trustees of CHEST Foundation, receiving reimbursement for travel expenses.
  • Medical Education Resources, receiving reimbursement for travel expenses and honoraria.

Stanton T. Siu, MD

Dr. Siu is a board certified internist, pulmonary and critical care physician. He is the Chief of Critical Care and Pulmonary Medicine, and is Director of Graduate and Undergraduate Medical Education for the Kaiser Permanente East Bay in Northern California. He is a Full Clinical Professor at the University of California, San Francisco (UCSF). His career has centered around medical education in different venues.

Previously, Dr. Siu served at the Kaiser Permanente Oakland Medical Center as Assistant Chief of Medicine for two years and was a Program Director for the Internal Medicine Residency Program there for 11 years.

Currently, Dr. Siu is chairman of several committees, including the Kaiser Oakland Graduate Medical Education Committee, the Kaiser East Bay Professionalism Council and the Kaiser Academy of Academicians. He also serves on other Kaiser East Bay committees, including the Critical Care Committee, the Subspecialty Medicine Chiefs Group, the Hospital Efficiency Committee, the Central Line Committee, the Procedural Sedation Committee, Pharmacy Residency Oversight Committee and the Radiation Safety Committee. Additionally, he serves on other Kaiser Northern California regional committees including the Pulmonary Chiefs Group, the Institutional Graduate Medical Education Committee and the Program Directors of Internal Medicine Committee.

Dr. Siu is also a member of the American Board of Internal Medicine Pulmonary Disease Board. He is a member of the Board of Directors of the UCSF - East Bay Surgery Residency Foundation and a member of the UCSF School of Medicine's Admission Committee.

Dr. Siu earned his medical degree at the University of Hawaii John A. Burns School of Medicine. He completed his residency and chief residency in internal medicine at Kaiser Foundation Hospital in Oakland, California, and later completed his fellowship training in pulmonary and critical care at Harbor-UCLA Medical Center in Los Angeles.

As of January 2017, Dr. Siu reported the following external relationships:

Dr. Siu serves in significant roles with the following healthcare-related organizations, receiving reimbursement or compensation as listed:

  • UCSF East Bay Surgery Residency Foundation, serving on the Board of Directors, without compensation.
  • Kaiser Permanente Institutional Graduate Medical Education, serving as a Committee Member, without compensation.

Lynn T. Tanoue, MD

Dr. Tanoue, who is board certified in Internal Medicine, Pulmonary Disease and Critical Care Medicine, is Professor of Medicine and Clinical Chief of the Section of Pulmonary, Critical Care, and Sleep Medicine, and Vice-Chair for Clinical Affairs in the Department of Internal Medicine at Yale School of Medicine in New Haven, Connecticut. She co­directs the Yale Thoracic Oncology Program and the Yale Screening and Nodule Program at Smilow Cancer Hospital at Yale-New Haven, and is the principal investigator of the Yale Lung Cancer Biorepository. Her academic focus is in the field of thoracic oncology.

Dr. Tanoue is currently Chair of the American Board of Internal Medicine (ABIM) Pulmonary Disease Board Exam Committee and a member of the ABIM Pulmonary Disease Board. She is Chair of the American College of Chest Physicians Thoracic Oncology Network Steering Committee. She is Chair of the American Thoracic Society Thoracic Oncology Assembly. She is a former President of the National Association for Medical Direction of Respiratory Care.

Dr. Tanoue received her bachelor's degree from Harvard University and medical degree from Yale School of Medicine. She did her internal medicine residency, chief residency and a fellowship in pulmonary/critical care medicine at Yale-New Haven Hospital.

As of January 2017, Dr. Tanoue reported the following external relationships:

Work as an author or editor for the following companies, with compensation as listed:

  • UpToDate, receiving compensation for authorship.
  • Elsevier, receiving compensation as an Editor of “Year Book of Pulmonary Disease.”

Dr. Tanoue serves in significant roles with the following healthcare-related organization, receiving reimbursement or compensation as listed:

  • American Thoracic Society, Program Chair, Thoracic Oncology Assembly, without compensation.

Dr. Tanoue serves as a consultant to the Norwalk Hospital Thoracic Tumor Board, receiving honoraria.